Liangren Liu

Sichuan University

Papers

2

Total Citations

44

H-Index

2

About

Dr. Liangren Liu is a leading urologic surgeon and researcher whose work centers on optimizing surgical outcomes in robot-assisted partial nephrectomy (RAPN) for renal tumors. His major contributions lie in two critical, evidence-based debates: the choice between retroperitoneal and transperitoneal surgical approaches, and the decision to clamp or not clamp the renal artery during surgery. In his highly cited 2021 meta-analysis (25 citations), Dr. Liu systematically compared retroperitoneal versus transperitoneal RAPN, providing surgeons with clear, data-driven guidance on perioperative outcomes. That same year, he published another influential meta-analysis (19 citations) that offered the largest pooled analysis to date comparing off-clamp and on-clamp techniques, evaluating not only perioperative safety but also long-term renal functional and oncological outcomes. Through these rigorous, updated evidence syntheses, Dr. Liu has directly shaped clinical decision-making, helping urologists worldwide tailor their surgical approach to maximize patient benefit. His work exemplifies how high-quality meta-analyses can resolve longstanding surgical controversies and improve standards of care in minimally invasive oncology.

Research Focus

Key Achievements

2
H-Index
2
Papers
44
Total Citations
22
Avg Citations/Paper
🏆 Most Cited Paper
Retroperitoneal or transperitoneal approach in robot‐assisted partial nephrectomy, which one is better?
25 citations · 2021
📈 Most Prolific Year: 2021 (2 Papers)
🤝 Key Collaborators: 14
🏛 Institutions: Sichuan University

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago